EE200100660A - Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake - Google Patents
Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerakeInfo
- Publication number
- EE200100660A EE200100660A EEP200100660A EEP200100660A EE200100660A EE 200100660 A EE200100660 A EE 200100660A EE P200100660 A EEP200100660 A EE P200100660A EE P200100660 A EEP200100660 A EE P200100660A EE 200100660 A EE200100660 A EE 200100660A
- Authority
- EE
- Estonia
- Prior art keywords
- acid
- microsphere
- formulation
- preparation
- labile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99110865 | 1999-06-07 | ||
PCT/EP2000/004958 WO2000074654A1 (en) | 1999-06-07 | 2000-05-31 | Novel preparation and administration form comprising an acid-labile active compound |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100660A true EE200100660A (et) | 2003-04-15 |
Family
ID=8238296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100660A EE200100660A (et) | 1999-06-07 | 2000-05-31 | Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake |
Country Status (31)
Country | Link |
---|---|
US (3) | US7794752B1 (zh) |
EP (2) | EP1616562A1 (zh) |
JP (1) | JP4980527B2 (zh) |
KR (1) | KR100833633B1 (zh) |
CN (1) | CN1361683A (zh) |
AT (1) | ATE300285T1 (zh) |
AU (1) | AU775995B2 (zh) |
BG (1) | BG106165A (zh) |
BR (1) | BR0011347A (zh) |
CA (1) | CA2376202C (zh) |
CZ (1) | CZ20014405A3 (zh) |
DE (1) | DE60021570T2 (zh) |
DK (1) | DK1187601T3 (zh) |
EA (2) | EA006899B1 (zh) |
EE (1) | EE200100660A (zh) |
ES (1) | ES2246238T3 (zh) |
HK (1) | HK1046643A1 (zh) |
HR (1) | HRP20020006A2 (zh) |
HU (1) | HUP0201637A3 (zh) |
IL (2) | IL146504A0 (zh) |
MX (1) | MXPA01012659A (zh) |
NO (1) | NO20015980L (zh) |
PL (1) | PL352882A1 (zh) |
PT (1) | PT1187601E (zh) |
SI (1) | SI1187601T1 (zh) |
SK (1) | SK285247B6 (zh) |
TR (1) | TR200103527T2 (zh) |
UA (1) | UA74339C2 (zh) |
WO (1) | WO2000074654A1 (zh) |
YU (1) | YU86001A (zh) |
ZA (1) | ZA200110000B (zh) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE0100823D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method I to obtain microparticles |
US7988999B2 (en) | 2000-12-07 | 2011-08-02 | Nycomed Gmbh | Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
DK1341528T3 (da) * | 2000-12-07 | 2012-03-26 | Nycomed Gmbh | Hurtigtopløsende tablet omfattende en syrelabil aktiv bestanddel |
BR0115989A (pt) * | 2000-12-07 | 2004-01-13 | Altana Pharma Ag | Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido |
JP4310605B2 (ja) * | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
US20040005362A1 (en) * | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
MXPA04008070A (es) | 2003-03-10 | 2004-11-26 | Altana Pharma Ag | Novedoso proceso para la preparacion de roflumilasto. |
TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
CL2004000983A1 (es) | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
PE20050150A1 (es) | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
WO2005074898A2 (en) * | 2004-01-28 | 2005-08-18 | Altana Pharma Ag | Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori |
US20060134210A1 (en) * | 2004-12-22 | 2006-06-22 | Astrazeneca Ab | Solid dosage form comprising proton pump inhibitor and suspension made thereof |
JP5383183B2 (ja) | 2005-03-16 | 2014-01-08 | タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロフルミラストを含有する矯味された剤形 |
EP1937642B1 (en) | 2005-10-19 | 2014-09-10 | Teva Pharmaceutical Industries Ltd | Crystals of laquinimod sodium, and process for the manufacture thereof |
WO2007146248A2 (en) | 2006-06-12 | 2007-12-21 | Teva Pharmaceutical Industries, Ltd. | Stable laquinimod preparations |
US20090318403A1 (en) * | 2006-08-03 | 2009-12-24 | Prosensa Technologies B.V. | Antibiotic composition |
CN101516334B (zh) | 2006-09-26 | 2013-07-10 | 塔罗制药北美有限公司 | 用于抗生素的稳定组合物以及应用方法 |
ES2600920T3 (es) | 2007-12-20 | 2017-02-13 | Teva Pharmaceutical Industries, Ltd. | Preparaciones estables de laquinimod |
KR101094231B1 (ko) | 2008-02-18 | 2011-12-14 | 하나제약 주식회사 | 서방성 고형 제제 및 그의 제조방법 |
CA2719246A1 (en) * | 2008-03-26 | 2009-10-01 | Taro Pharmaceuticals North America, Inc. | Stabilizing lipid compositions for oral pharmaceutical agents |
WO2010018593A2 (en) * | 2008-07-03 | 2010-02-18 | Torrent Pharmaceuticals Ltd. | Gastric acid resistant benzimidazole multiple unit tablet composition |
AU2009288108B2 (en) | 2008-09-03 | 2013-10-17 | Teva Pharmaceutical Industries, Ltd. | 2-oxo-1,2-dihydro-quinoline modulators of immune function |
KR101107609B1 (ko) * | 2009-09-21 | 2012-01-25 | 주식회사 한양비이에스티교육 | 태양에너지 발전 및 응용 교육을 위한 보트형 학습교재 |
EP2338477A1 (en) | 2009-12-15 | 2011-06-29 | bene-Arzneimittel GmbH | Suppository comprising pantoprazole |
US8580819B2 (en) | 2010-07-09 | 2013-11-12 | Teva Pharmaceutical Industries Ltd. | Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
WO2012171540A1 (en) | 2011-06-15 | 2012-12-20 | Bene-Arzneimittel Gmbh | Suppository comprising pantoprazole comprised in pellets with a cellulose core |
AR090073A1 (es) | 2012-02-16 | 2014-10-15 | Teva Pharma | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos |
TW201350467A (zh) | 2012-05-08 | 2013-12-16 | Teva Pharma | N-乙基-4-羥基-1-甲基-5-(甲基(2,3,4,5,6-五羥基己基)胺基)-2-側氧-n-苯基-1,2-二氫喹啉-3-甲醯胺 |
EP2916915A4 (en) | 2012-11-07 | 2016-06-22 | Teva Pharma | LAQUINIMOD AMINE SALTS |
AU2014350208B2 (en) * | 2013-11-13 | 2017-09-07 | Tillotts Pharma Ag | Multi-particulate drug delivery system |
CN107412171B (zh) * | 2017-04-21 | 2020-04-17 | 湖南赛隆药业有限公司 | 注射用左旋泮托拉唑钠长效微球冻干制剂及其制备方法 |
CN107007561B (zh) * | 2017-04-21 | 2019-12-03 | 湖南赛隆药业有限公司 | 一种左旋泮托拉唑钠缓释微球及其制备方法 |
WO2019161175A1 (en) | 2018-02-15 | 2019-08-22 | Boston Scientific Scimed, Inc. | Introducer with expandable capabilities |
JP2022522114A (ja) * | 2019-02-21 | 2022-04-14 | クロマデックス,インコーポレイテッド | ニコチンアミドリボシド、ニコチン酸リボシド、還元ニコチニルリボシド化合物、及びニコチニルリボシド化合物誘導体の製剤への使用 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE27C (de) * | 1877-08-02 | GRAHL und HÖHL zu Dresden | Akkumulator zum Betriebe von Hutpressen | |
US3065142A (en) * | 1958-07-30 | 1962-11-20 | Armour Pharma | Gastric resistant medicinal preparation |
US3800038A (en) * | 1972-04-21 | 1974-03-26 | Biolog Concepts Inc | Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier |
DE2725924C3 (de) * | 1977-06-08 | 1980-11-06 | Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau | Verfahren zur Herstellung kugelförmiger Teilchen aus niedrigschmelzenden organischen Substanzen |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
NO152588C (no) | 1979-12-19 | 1985-10-23 | Goudsche Machinefabriek Bv | Kontinuerlig arbeidende krystallisator. |
JPS58116471A (ja) | 1981-12-29 | 1983-07-11 | Nippon Kayaku Co Ltd | 4−ヒドロキシメチル−1−フタラゾンエステル誘導体およびその塩 |
US4637966A (en) * | 1983-10-21 | 1987-01-20 | Gates Energy Products, Inc. | Sealed lead-acid cell |
US4876094A (en) * | 1984-01-13 | 1989-10-24 | Battelle Development Corporation | Controlled release liquid dosage formulation |
JPS60248618A (ja) * | 1984-05-24 | 1985-12-09 | Nippon Zoki Pharmaceut Co Ltd | ジペプチドを含有する潰瘍治療剤 |
IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU4640985A (en) | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
JO1406B1 (en) | 1984-11-02 | 1986-11-30 | سميث كلاين اند فرينش لابوراتوريز ليمتد | Chemical compounds |
DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
EP0234485B1 (de) | 1986-02-20 | 1992-04-01 | Hoechst Aktiengesellschaft | Substituierte Thienoimidazol-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer |
GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
CA1256109A (en) | 1986-09-10 | 1989-06-20 | Franz Rovenszky | Process for the preparation of derivatives of 4, 5-dihydrooxazoles |
FI90544C (fi) | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
JPH0768125B2 (ja) | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
JP2681373B2 (ja) | 1988-07-18 | 1997-11-26 | 塩野義製薬株式会社 | 徐放性製剤の製造法 |
EP0434999B1 (en) | 1989-11-29 | 1994-08-17 | Toa Eiyo Ltd. | Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same |
FR2657257B1 (fr) * | 1990-01-19 | 1994-09-02 | Rhone Poulenc Sante | Procede de preparation de medicaments sous forme de perles. |
US5213810A (en) * | 1990-03-30 | 1993-05-25 | American Cyanamid Company | Stable compositions for parenteral administration and method of making same |
DE4018642C2 (de) | 1990-06-11 | 1993-11-25 | Byk Gulden Lomberg Chem Fab | Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes |
DE4022648C2 (de) | 1990-07-17 | 1994-01-27 | Nukem Gmbh | Verfahren und Vorrichtung zur Herstellung von kugelförmigen Teilchen aus flüssiger Phase |
TW209174B (zh) * | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
YU48263B (sh) | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
KR0141909B1 (ko) * | 1991-11-08 | 1998-06-15 | 보조 다꾸로 | 액정 표시 디바이스 제조 방법 |
JP2973751B2 (ja) * | 1991-12-04 | 1999-11-08 | 大正製薬株式会社 | 矯味経口組成物の製造方法 |
TW272942B (zh) * | 1993-02-10 | 1996-03-21 | Takeda Pharm Industry Co Ltd | |
FR2707184B1 (fr) * | 1993-07-08 | 1995-08-11 | Rhone Poulenc Nutrition Animal | Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique. |
EP0995447A1 (en) * | 1993-09-09 | 2000-04-26 | Takeda Chemical Industries, Ltd. | Formulation comprising antibacterial substance and antiulcer substance |
NL9400618A (nl) | 1994-04-18 | 1995-12-01 | Goudsche Machinefabriek Bv | Inrichting voor het koelen en verwerken van een gesmolten produkt tot een granulaatprodukt. |
CZ289804B6 (cs) | 1994-07-08 | 2002-04-17 | Astrazeneca Ab | Multijednotková tabletovaná dávková forma I |
SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
SE512835C2 (sv) | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
US5972389A (en) * | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
FR2754177B1 (fr) | 1996-10-07 | 1999-08-06 | Sanofi Sa | Microspheres pharmaceutiques d'acide valproique pour administration orale |
WO1998020858A1 (en) * | 1996-11-12 | 1998-05-22 | Pharmacia & Upjohn Ab | COMPACT MEMBER COMPRISING A PLURALITY OF POROUS CELLULOSE MATRICES, (PCMs), METHOD OF MANUFACTURING AND USE THEREOF |
GB9710800D0 (en) | 1997-05-23 | 1997-07-23 | Cipla Limited | Pharmaceutical composition and method of preparing it |
ID20812A (id) * | 1997-07-09 | 1999-03-11 | Takeda Chemical Industries Ltd | Senyawa polyol, produk dan penggunaannya |
AU8699298A (en) * | 1997-08-11 | 1999-03-01 | Alza Corporation | Prolonged release active agent dosage form adapted for gastric retention |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
AU751066B2 (en) * | 1997-12-08 | 2002-08-08 | Nycomed Gmbh | Novel administration form comprising an acid-labile active compound |
NL1007904C2 (nl) | 1997-12-24 | 1999-06-25 | Goudsche Machinefabriek Bv | Werkwijze en inrichting voor het vormen van granulaat uit een smelt van chemische producten. |
CN1293576A (zh) * | 1998-03-20 | 2001-05-02 | 兴和株式会社 | 胃和/或十二指肠粘附性药物组合物 |
DK173431B1 (da) | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
US6632457B1 (en) * | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
JP4370429B2 (ja) | 1998-09-10 | 2009-11-25 | 東和薬品株式会社 | 徐放性マイクロスフエアの製造法 |
DE19848849A1 (de) | 1998-10-22 | 2000-04-27 | Knoll Ag | Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz |
-
2000
- 2000-05-31 DE DE60021570T patent/DE60021570T2/de not_active Expired - Lifetime
- 2000-05-31 ES ES00935151T patent/ES2246238T3/es not_active Expired - Lifetime
- 2000-05-31 HU HU0201637A patent/HUP0201637A3/hu unknown
- 2000-05-31 CA CA002376202A patent/CA2376202C/en not_active Expired - Fee Related
- 2000-05-31 EP EP05104345A patent/EP1616562A1/en not_active Withdrawn
- 2000-05-31 DK DK00935151T patent/DK1187601T3/da active
- 2000-05-31 SI SI200030755T patent/SI1187601T1/sl unknown
- 2000-05-31 YU YU86001A patent/YU86001A/sh unknown
- 2000-05-31 PL PL00352882A patent/PL352882A1/xx unknown
- 2000-05-31 EP EP00935151A patent/EP1187601B1/en not_active Expired - Lifetime
- 2000-05-31 UA UA2002010191A patent/UA74339C2/uk unknown
- 2000-05-31 EE EEP200100660A patent/EE200100660A/xx unknown
- 2000-05-31 IL IL14650400A patent/IL146504A0/xx active IP Right Grant
- 2000-05-31 MX MXPA01012659A patent/MXPA01012659A/es active IP Right Grant
- 2000-05-31 WO PCT/EP2000/004958 patent/WO2000074654A1/en active IP Right Grant
- 2000-05-31 CN CN00808668A patent/CN1361683A/zh active Pending
- 2000-05-31 BR BR0011347-6A patent/BR0011347A/pt not_active Application Discontinuation
- 2000-05-31 KR KR1020017015776A patent/KR100833633B1/ko not_active IP Right Cessation
- 2000-05-31 US US09/980,492 patent/US7794752B1/en not_active Expired - Fee Related
- 2000-05-31 TR TR2001/03527T patent/TR200103527T2/xx unknown
- 2000-05-31 JP JP2001501191A patent/JP4980527B2/ja not_active Expired - Fee Related
- 2000-05-31 CZ CZ20014405A patent/CZ20014405A3/cs unknown
- 2000-05-31 PT PT00935151T patent/PT1187601E/pt unknown
- 2000-05-31 EA EA200401241A patent/EA006899B1/ru not_active IP Right Cessation
- 2000-05-31 SK SK1802-2001A patent/SK285247B6/sk not_active IP Right Cessation
- 2000-05-31 AT AT00935151T patent/ATE300285T1/de not_active IP Right Cessation
- 2000-05-31 AU AU50741/00A patent/AU775995B2/en not_active Ceased
- 2000-05-31 EA EA200101266A patent/EA005803B1/ru not_active IP Right Cessation
-
2001
- 2001-11-14 IL IL146504A patent/IL146504A/en not_active IP Right Cessation
- 2001-12-03 BG BG06165A patent/BG106165A/bg unknown
- 2001-12-05 ZA ZA200110000A patent/ZA200110000B/xx unknown
- 2001-12-06 NO NO20015980A patent/NO20015980L/no not_active Application Discontinuation
-
2002
- 2002-01-04 HR HR20020006A patent/HRP20020006A2/hr not_active Application Discontinuation
- 2002-11-18 HK HK02108341.7A patent/HK1046643A1/zh unknown
-
2006
- 2006-02-09 US US11/349,969 patent/US7790198B2/en not_active Expired - Fee Related
-
2007
- 2007-10-31 US US11/980,572 patent/US7785630B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100660A (et) | Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
PT91246A (pt) | Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo | |
BR9912975A (pt) | Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso | |
BR8801242A (pt) | Processo de preparar uma composicao para fornecer uma quantidade efetiva de uma dose constante de um ingrediente ativo a um animal e a respectiva composicao | |
PT100234A (pt) | Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao | |
ATE427925T1 (de) | Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe | |
PT95312A (pt) | Processo para a preparacao de novos tienilcarboxilatos de aminoalcoois e dos seus produtos de quaternizacao, e de composicoes farmaceuticas que os contem | |
IT1230742B (it) | Composizione per aerosol comprendente nitroglicerina come ingrediente attivo. | |
CA2240728A1 (en) | Kappa agonist compounds and pharmaceutical formulations thereof | |
DE59711477D1 (de) | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe | |
MY138975A (en) | Novel preparation and administration form comprising an acid-labile active compound | |
ES2027773T3 (es) | Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea. | |
KR970703131A (ko) | 소수성 활성물질과 발포제를 포함하는 제약학적 조성물과 이의 준비공정(pharmaceutical preparation with a hydrophobic active substance and an effer vescent system, and process for preparing said preparation) | |
ATE332894T1 (de) | Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe | |
BR9706214A (pt) | Composições farmacêuticas de liberação controlada para administração oral contendo nifedipina como substância ativa e processo para a preparação de composiç es farmacêuticas para a administração oral contendo nifedipina como substância ativa | |
BR9404225A (pt) | Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações | |
PT95810A (pt) | Processo para a preparacao de composicoes farmaceuticas injectaveis contendo um alcaloide de bis-indol como ingrediente activo | |
RU94012554A (ru) | Шампунь, обладающий противопедикулезным действием, его состав и способ изготовления | |
NO950950L (no) | Farmasöytisk preparat | |
GB9711032D0 (en) | Compound as a stimulant for the central nervous system | |
DE59205998D1 (de) | Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
AU2506188A (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
TH27208A (th) | สารผสมที่เสถียรของส่วนผสมออกฤทธิ์ที่ไม่เข้ากันเพื่อใช้อารักขาพืช |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC1A | Change of owner name |